 "Covid-19 vaccine: Real-world data to decide commercial marketing approval")
The drug regulator may consider real-world data from the ongoing Covid-19 vaccinations to grant faster commercial marketing approval to the vaccine candidates, according to sources in the know.
Commercial nod would mean that the manufacturer can sell it in the private market with a specified maximum retail price. Vaccines are typically sold through hospitals or paediatricians for administering doses to infants or young children. Vaccine makers are now not allowed to commercially sell it as they have been granted ‘restricted emergency-use’ approval, which allows them to sell only to the Indian government which, in turn, distributes the vaccines.
Commercial nod would mean that the manufacturer can sell it in the private market with a specified maximum retail price. Vaccines are typically sold through hospitals or paediatricians for administering doses to infants or young children. Vaccine makers are now not allowed to commercially sell it as they have been granted ‘restricted emergency-use’ approval, which allows them to sell only to the Indian government which, in turn, distributes the vaccines.
